EP3189044

CRYSTALLINE (2S)-3-[(3S,4S)-3-[(1R)-1-HYDROXYETHYL]-4-(4-METHOXY-3-{[1-(5-METHYLPYRIDIN-2-YL)AZETIDIN-3-YL]OXY}PHENYL) -3-METHYLPYRROLIDIN-1-YL]-3-OXOPROPANE-1,2-DIOL

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    28.8.2015
  • :
    1.8.2018
  • :
    15762875.1
  • :
    27.8.2035
  • :
    CRYSTALLINE (2S)-3-[(3S,4S)-3-[(1R)-1-HYDROXYETHYL]-4-(4-METHOXY-3-{[1-(5-METHYLPYRIDIN-2-YL)AZETIDIN-3-YL]OXY}PHENYL) -3-METHYLPYRROLIDIN-1-YL]-3-OXOPROPANE-1,2-DIOL

28.8.2015
1.8.2018
  • :
    Eli Lilly and Company
  • :
    Lilly Corporate Center, 46285, Indianapolis, IN, US
  • :
    HUANG, Ping
  • :
    Indianapolis, Indiana, US
  • :
    RIBE, Seth Dietrich
  • :
    Indianapolis, Indiana, US
  • :
    PCT/CN2014/085925
  • :
    4.9.2014
  • :
    WO
  • :
    US2015047415
  • :
    28.8.2015
  • :
    C07D 401/14, A61K 31/4439, A61P 13/10